Lifestyle Modification and Incretin-Based Therapy for Obesity

This JAMA Insights discusses strategies for lifestyle modifications and managing adverse effects for individuals with obesity receiving incretin-based therapies for weight loss.

Corresponding Author: Robert F. Kushner, MD, Northwestern University Feinberg School of Medicine, 645 N Michigan Ave, Ste 530, Chicago, IL 60611 (rkushner@northwestern.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.